11646

協賛企業

Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.

著者 Bucci FA , Waterbury LD
J Cataract Refract Surg.2008 Sep ; 34(9):1509-12.
この記事をPubMed上で見るPubMedで表示

Bucci Laser Vision Institute, 158 Wilkes-Barre Township Boulevard, Wilkes-Barre, PA 18702, USA. buccivision@aol.com

(14view , 0users)
PURPOSE: To compare aqueous drug concentrations and prostaglandin E(2) (PGE(2)) levels in patients treated with ketorolac 0.4% and bromfenac 0.09% at trough dosing. SETTING: Private practice, Wilkes-Barre, Pennsylvania, USA. METHODS: This single-center randomized investigator-masked clinical study comprised 56 patients having cataract surgery. Patients received 1 drop of ketorolac 0.4% or bromfenac 0.09% 6 hours and 12 hours preoperatively consistent with on-label dosing schedules. Aqueous humor was collected at the start of surgery and analyzed for concentrations of ketorolac and bromfenac using a reverse-phase high-performance liquid chromatography-mass spectroscopy system and for PGE(2) levels by competitive enzyme immunoassay. RESULTS: The mean aqueous PGE(2) level was 204.2 pg/mL +/- 95.5 (SD) in patients treated with ketorolac 0.4% and 263.7 +/- 90.0 pg/mL in patients treated with bromfenac 0.09%, (P = .020). The mean aqueous concentration of ketorolac and bromfenac at trough dosing was 130.5 +/- 37.8 ng/mL and 6.2 +/- 3.1 ng/mL, respectively (P = .004). CONCLUSIONS: Higher aqueous levels and greater PGE(2) inhibition were observed in cataract surgery patients treated with ketorolac 0.4% than in patients treated with bromfenac 0.09% at trough dosing. These findings suggest that ketorolac 0.4% administered 4 times a day may provide better control of prostaglandin-mediated inflammation than bromfenac 0.09% administered twice a day.
PMID: 18721711 [PubMed - indexed for MEDLINE]
保存論文に追加 保存論文に追加

論文ランキング

週間人気論文ランキング - 閲覧数 (2010/07/24/ 09時更新)

Effects of bacterial toxins on endothelial tight junction in vitro: a mechanism-based investigation.

先週: 1位 ranksame 245view,2users 保存 要約を見る 要約

Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy.

先週: 3位 rankup 182view,0users 保存 要約を見る 要約

Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients.

先週: 8位 rankup 78view,11users 保存 要約を見る 要約

Personality disorders and biosocial trait theories: The argument for radical legal reform.

先週: 2位 rankdown 76view,2users 保存 要約を見る 要約

The differentiation of rat adipose-derived stem cells into OEC-like cells on collagen scaffolds by co-culturing with OECs.

先週: 9位 rankup 68view,11users 保存 要約を見る 要約

Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

先週: 5位 rankdown 68view,0users 保存 要約を見る 要約

Integration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts.

先週: 7位 ranksame 64view,1users 保存 要約を見る 要約

A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study.

先週: 10位 rankup 34view,28users 保存 要約を見る 要約

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

先週: 6位 rankdown 34view,0users 保存 要約を見る 要約

An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).

先週: 4位 rankdown 30view,0users 保存 要約を見る 要約
※view数:週間 user数:合計